Clinitech Laboratory was incorporated on March 19, 2010. The company provides diagnostic and healthcare tests, and services through a chain of 8 diagnostic centres in and around Thane and Navi Mumbai.
| Bidding Dates |
|---|
| 25 Jul 2024 - 29 Jul 2024 |
| Subscription |
|---|
| 37x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,15,200 | 1 | 1 | 1200 | 602.4 K | ₹96 | 61.58 % | ₹57.8 M | RHP DOC |
Clinitech Laboratory IPO SUBSCRIPTION STATUS
29 Jul '24Clinitech Laboratory IPO overall subscription rate was 37 times the total available shares
Clinitech Laboratory IPO retail subscription rate was 49.61 times in the retail segment
Clinitech Laboratory IPO non-institutional investor subscription rate was 24.39 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
29 Jul 2024 (Day 3) | 49.61x | 24.39x | - |
26 Jul 2024 (Day 2) | 10.1x | 1.44x | - |
25 Jul 2024 (Day 1) | 4.33x | 0.62x | - |
Clinitech Laboratory FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) | Margins |
| FY24 | 3.7 | 64.0 | 1.1 | -10.9 | 15.9% |
| FY23 | 6.1 | 63.5 | 12.5 | 9.7 | 21.5% |
| FY22 | 5.1 | 63.8 | 9.6 | -5.6 | 17.6% |
Clinitech Laboratory IPO SUBSCRIPTION STATUS DETAILS
Clinitech Laboratory had 602.4 K shares on offer
Clinitech Laboratory IPO offer price was ₹96
Clinitech Laboratory IPO minimum Investment was ₹115200
Clinitech Laboratory IPO issue size was ₹ 57.8 M
Clinitech Laboratory had a minimum lot size of 1200 Shares per application
Clinitech Laboratory NUMBER OF SHARES ON OFFER
Clinitech Laboratory IPO IMPORTANT DATES
| Issue Open Date | 25 Jul 2024 |
| Issue close Date | 29 Jul 2024 |
| Allotment Date | 30 Jul 2024 |
| Refund Date | 31 Jul 2024 |
| Demat Account Credit Date | 31 Jul 2024 |
| Listing Date | 01 Aug 2024 |
| Listing on Exchange(s) | BSE |
| Clinitech Laboratory Allotment Status | Exchange |
Clinitech Laboratory IPO subscription opened on 25 Jul 2024, and closed on 29 Jul 2024
IPO allotment for Clinitech Laboratory was finalized on Tuesday, 30 Jul 2024
IPO listing for Clinitech Laboratory was on BSE on Thursday, 01 Aug 2024
Clinitech Laboratory IPO LISTING GAINS
| Issue Price (adjusted) | 96.0 |
| Listing Open Price | 115.0 |
| Listing Close Price | 120.8 |
| Listing Gain% | 19.8% |
| Current Gain% | -58.3% |
Clinitech Laboratory Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinitech Laboratory Ltd. | 40 | 9.1 | 22 | 0.9 | 4.5 | 3.7 | 9.7 | 0.4 | 1.8 | ||||
| Dr. Lal Pathlabs Ltd. | 1931.6 | 32421.7 | 59.8 | 10.7 | 11.2 | 20.1 | 16 | 2864.2 | 12.1 | 504.8 | 3.6 | 32.3 | 5.6 |
| Inventurus Knowledge Solutions Ltd. | 1737.7 | 29814.3 | 39 | 1 | 8.9 | 25.8 | 16.9 | 3211 | 18.8 | 721.6 | 48.4 | 44.5 | 40.9 |
| Vijaya Diagnostic Centre Ltd. | 1351.1 | 13916 | 74.2 | 3 | 16.2 | 18.1 | 11.5 | 835 | 19.3 | 173 | 20.9 | 18.2 | 24.9 |
| Indegene Ltd. | 554.4 | 13357.5 | 33.3 | -4.2 | 3.5 | 12.8 | 8.7 | 3582.5 | 21.6 | 401.1 | -1.4 | 16.6 | -7.9 |
| Metropolis Healthcare Ltd. | 563.2 | 11680.1 | 57.9 | 1.8 | 6.8 | 12.6 | 8.9 | 1671.4 | 24.1 | 190 | 31.1 | 9.7 | 32.6 |
Clinitech Laboratory INFORMATION ON IPO ISSUE
About Clinitech Laboratory
Clinitech Laboratory was incorporated on March 19, 2010. The company provides diagnostic and healthcare tests, and services through a chain of 8 diagnostic centres in and around Thane and Navi Mumbai.
Object of the Issue
- Expansion of diagnostic centres
- General corporate purposes
Clinitech Laboratory - PROMOTERS
| Name |
|---|
| Jagdish Umakant Nayak |
| Jyoti Jagdish Nayak |
Clinitech Laboratory Lead Manager of the Issue
Inventure Merchant Banker Services Private Limited
compliance@inventuremerchantbanker.com
Clinitech Laboratory Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Clinitech Laboratory Strengths
NABL accreditation
The company has been awarded the certificate of accreditation by NABL (National Accreditation Board for Testing and Calibration Laboratories) under ISO 15189:2012 for its facilities in the medical testing at Airoli, Navi Mumbai
Chain of diagnostic centers
The company provides diagnostic and healthcare tests and services through a chain of 8 diagnostic centers in and around Thane, Raigad, and Navi Mumbai
Long-standing customer relationships
The company's three-decade-long experience and client relationships help it to get repeat business from the customers. Its client relationships enable it to cross-sell its other products and services
Clinitech Laboratory Risks
Geographically concentrated
The company's operations are concentrated in Thane and Navi Mumbai, and any loss of business in such regions could adversely affect the business, results of operations, and financial condition
Highly competitive industry
The company operates in a highly competitive industry, therefore, its revenues, profits or market share could be harmed if it is unable to compete effectively
Negative cash flows
The company has experienced negative cash flows in the past. Any such negative cash flows in the future could adversely affect the business, results of operations, and prospects
IPO FAQs
The promoters of the company are Jagdish Umakant Nayak and Jyoti Jagdish Nayak.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 96.0 - 96.0.
The IPO application opens on Jul 25, 2024 and closes on Jul 29, 2024.
The minimum lot size for the IPO is 1200. The maximum lot size for the IPO is 1200.
For all category investors, the minimum application amount for this IPO is Rs. 115,200.0, the maximum value for this IPO is Rs 115,200.0.
This IPO will be allotted on Jul 30, 2024.
The refund will be credited to your account on Jul 31, 2024.
The allotted shares will be credited to your demat on Jul 31, 2024.
Clinitech Laboratory Ltd.’s shares listed on the stock exchanges on Aug 01, 2024.